Integrated HIV prevention and care strengthens primary health care: Lessons from rural Haiti

Journal of Public Health Policy

Volumn 25, Issue 2, 2004, Pages 137-158

  Walton, David A ^a   Farmer, Paul E ^a   Lambert, Wesler ^a   Léandre, Fernet ^a   Koenig, Serena P ^a   Mukherjee, Joia S ^a  

^a NONE

Author keywords

AIDS; Global health equity; HIV; Primary health care

Indexed keywords

ANTIRETROVIRUS AGENT; TUBERCULOSTATIC AGENT; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CASE FINDING; CAUSE OF DEATH; COMMUNITY CARE; FAMILY PLANNING; HAITI; HEALTH CARE DISTRIBUTION; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH PROMOTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; POVERTY; PRIMARY HEALTH CARE; RURAL AREA; SEXUALLY TRANSMITTED DISEASE; SHORT COURSE THERAPY; SIDE EFFECT; TUBERCULOSIS; VACCINATION;

ADULT; ANTI-HIV AGENTS; FEMALE; HAITI; HIV INFECTIONS; HUMANS; MALE; POVERTY; PRIMARY HEALTH CARE; RURAL HEALTH; TUBERCULOSIS;

EID: 2942750037     PISSN: 01975897     EISSN: None     Source Type: Journal    
DOI: 10.1057/palgrave.jphp.3190013     Document Type: Article

References (50)

1. Declaration of Alma Ata. International Conference of Primary Health Care, Alma Ata, USSR, 6-12 September 1978. Available at: http://www. who.int/hpr/NPH/docs/declaration_almaata.pdf.
2. Heggenhougen HK. Will primary health care be allowed to succeed? Social Science and Medicine 1984; 19(3):217-24.
3. United Nations Food and Agriculture Organization. The State of Food Insecurity in the World. Rome: FAO, 2000. Available at: http://www.Hwww.fao.org/ DOCREP/X8200E/X8200E00.HTM.
4. U.S. Department of Health and Human Services. The Surgeon General's Call to Action to Decrease Overweight and Obesity 2001. Washington D.C., 2001. Available at: http//www.surgeongeneral.gov/topics/obesity/.
5. In a recent speech, Craig Calhoun, president of the Social Science Research Council, argued that cost-effectiveness models do not begin to capture the complex web of benefits resulting from AIDS treatment: "take the statement that antiretroviral drugs are expensive. This is surely true, whether or not the ARVs in question are generics, and whether or not drug companies need additional income to support new research. But it obscures another question: compared to what? If ARVs ward off opportunistic infections that would result in expensive hospital visits, how much does that save? If they help employers maintain skilled labor forces, how much does that save? If they keep schoolteachers alive so that more don't have to be trained, how much does that save? If they provide potential orphans with real, living parents, how much does that save? ... These are not just rhetorical questions. I mean them seriously. How much is saved? How do we integrate these factors into macroeconomic models in a meaningful way so that ministers of health and ministers of finance and ministers of education can be on the same page?" "U.S. and Multilateral Efforts to Fight HIV/AIDS: Are We Making Progress?" Bretton Woods Committee, 17 December 2003 . Available at: http://www.ssrc.org/ president_office/brettonwoodsaddress.page.
6. Talisuna AO, Bloland P, D'Alessandro U. History, dynamics, and public heath importance of malaria parasite resistance. Clinical Microbiology News 2004; 17:235-54.
7. Harvard Medical School, Open Society Institute. The Global Impact of Drug-Resistant Tuberculosis. Boston: Program in Infectious Disease and Social Change, Harvard Medical School, 1999.
8. WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world, Report No. 3. Geneva: World Health Organization, 2004.
9. Mayaud P, Hawkes S, Mabey D. Advances in control of sexually transmitted diseases in developing countries. Lancet 1998; 351(Supplement III):S29-S32.
10. Farmer PE. Infections and Inequalities: The Modern Plagues. Berkeley, CA: University of California Press, 1999.
11. "Uganda HIV project runs out of infant milk." All Africa 11 August 2003.
12. UNICEE HIV and Infant Feeding. New York: UNICEF, 2002.
13. Fauci AS. The AIDS epidemic: considerations for the 21st century. New England Journal of Medicine 1999; 341(14):1046-50.
14. Marseille E, Hofmann PB, Kahn JG. HIV Prevention before HAART in Sub-Saharan Africa. Lancet 2002; 359: 1851-56.
15. United Nations Food and Agriculture Organization. The State of Food Insecurity in the World. Rome: FAO, zooo. Available at: http://www.fao.org/ DOCREP/X8200E/X8200E00.HTM.
16. Farmer PE, Walton D. Condoms, coups, and ideology of prevention: facing failure in rural Haiti. In: Catholic Ethicists on HIV/AIDS Prevention. Continuum Publishing Group, 2000.
17. Mukherjee J, Farmer P, Léandre F, et al. Access to antiretroviral treatment and care: the HIV Equity Initiative, Cange, Haiti. Perspectives and Practice in Antiretroviral Treatment. Geneva: World Health Organization, 2003.
18. UNAIDS. Report on the Global HIV/AIDS Epidemic 2002. Geneva: UNAIDS, 2002.
19. World Health Organization. World Health Report 2003. Geneva: WHO, 2003.
20. Based on end 2001 case estimates. UNAIDS. Report on the Global HIV/AIDS Epidemic 2002. Geneva: UNAIDS 2002.
21. Pape JW, Liautaud B, Thomas F, et al. Characteristics of the acquired immunodeficiency syndrome (AIDS) in Haiti. New England Journal of Medicine 1983; 309(16):945-50.
22. Desvarieux M, Pape JW. HIV and AIDS in Haiti: recent developments. AIDS Care 1991; 3(3):271-79.
23. UNAIDS. Report on the Global HIV/AIDS Epidemic 2002. Geneva: UNAIDS 2002.
24. Farmer PE. AIDS and Accusation: Haiti and the Geography of Blame. Berkeley, CA: University of California Press, 1992.
25. I b i d.
26. Guérin J, Malebranche R, Elie R, et al. Acquired immune deficiency syndrome: Specific aspects of the disease in Haiti. Annals of the New York Academy of Sciences 437:254-61.
27. Pape JW, Johnson WD Jr. AIDS in Haiti: 1982-1992. Clinical Infectious Diseases 1993; 17 Supplement 2:S341-45.
28. The Département du Centre (along with Grand-Anse, in the south) has the lowest ratio of physicians to population and the smallest number of hospital beds per population. Ministry of Health and Population. AIDS: An epidemic that threatens Haitian development. Presented by the Haitian delegation at the United Nations National Assembly on HIV/AIDS, 25-27 June 2001, New York.
29. A 1998 study estimated that 66.1% of the population lived in poverty; 33%, in "extreme poverty." Centre de Recherche Appliquée. Enquête Projet de Marketing Social, 1998.
30. Rapport Trimestriel des Données de Base. Cange, Haiti: Zanmi Lasante, 1993.
31. Farmer PE. Haiti's lost years: Lessons for the Americas. Current Issues in Public Health 1996; 2:143-51.
32. Farmer PE. Letter from Haiti. AIDS Clinical Care 1997; 9(11): 83-85.
33. Farmer P, Léandre F, Mukherjee J, et al. Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy). Bulletin of the World Health Organization 2001; 79: 1145-1151.
34. Farmer PE, Robin S, Ramilus SL, et al. Tuberculosis, poverty, and "compliance": Lessons from rural Haiti. Seminars in Respiratory Infections 1991; 6(4):254-260.
35. Farmer PE, Leandre F, Mukherjee JS, et al. Community-based approaches to HIV treatment in resource-poor settings. Lancet 2001; 358:404-409.
36. Farmer PE, Léandre F, Bayona J, Louissant M. DOTS-Plus for the poorest of the poor: the Partners In Health experience in Haiti. International Journal of Tuberculosis and Lung Disease 2001; 5(11): S257.
37. Smith Fawzi MC, Lambert W, Singler JM, et al. Prevalence and risk factors of STDs in rural Haiti: implications for policy and programming in resource-poor settings. International Journal of STD & AIDS 2003; 14(12): 848-53.
38. Haiti's proposal to the Global Fund is available at: http://www.global- fundatm.org/proposals/round1/fsheets/haiti.html..
39. Farmer PE, Léandre F, Bayona J, Louissant M. DOTS-Plus for the poorest of the poor: the Partners In Health experience in Haiti. International Journal of Tuberculosis and Lung Disease 2001; 5(11): S257.
40. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993; 7: 95-102.
41. Gilson L, Mkanje R, Grosskurth H, et al. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza region, Tanzania. Lancet 1997; 350:1805-9.
42. Crofton J. The contribution of treatment to the prevention of tuberculosis. Bulletin of the International Union Against Tuberculosis 1962; 32:643-53.
43. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of Human Immunodeficiency Virus Type 1. New England Journal of Medicine 2000; 342: 921-29.
44. Blower S, Farmer P. Predicting the public heath impact of antiretrovirals; preventing HIV in developing countries. AID Science 2003; 3:11.
45. World Health Organization. WHO tuberculosis programme: framework for effective tuberculosis control. Geneva: World Heath Organization 1994.
46. Mitnick C, Bayona J, Palacios E, et al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. New England Journal of Medicine 2003; 348:119-28.
47. Cufino Svitone E, Garfield R, Vasconcelos MI, et al. Primary health care lessons from the northeast of Brazil: the Agentes de Saude Program. Pan American Journal of Public Health 2000; 7:2933-302.
48. Kim JY, Shakow A, Castro A, et al. Tuberculosis Control. In: Smith R, Beaglehole R, Woodward D, Drager N (eds.). Global Public Goods for Health. New York: Oxford University Press, 2003: 55-72.
49. World Health Organization. World Health Report 2003. Geneva. World Heath Organization, 2003.
50. Mukherjee JS. HIV-1 Care in resource-poor settings: a view from Haiti. Lancet 2003; 362: 994-95.